Sponsored Content | Webinar | Proton Therapy| October 13, 2016

WEBINAR: Economics of Establishing a Proton Therapy Center

This webinar is sponsored by IBA

IBA, proton therapy, economics of proton therapy, ROI of proton therapy, Proteus One

The webinar "Economics of Establishing a Proton Therapy Center," will help educate hospitals and oncology centers about the economics of building a proton therapy center and how it can potentially expand oncology services. IBA will take the mystery out of establishing a proton therapy center by walking attendees through the cost, staff, ROI and reimbursement management for a proton therapy center.

The webinar takes place Thursday, Nov. 3, 2016, 2-3 p.m. Eastern Time

Register for this webinar

 

Speakers

Joy Godby, BA, ROCC
Associate Director for Radiation Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

Godby manages the entire revenue cycle for radiation oncology (billing, coding, patient access, financial counseling, upfront appeals and back end appeals for all modalities). Her talk "Managing the Maze of Insurance authorization for Radiation Therapy" includes insights to reimbursement for oncology services.

 

Robert McElearney MBA
Vice President Strategic Accounts
IBA Proton Therapy North America

McElearney’s background in healthcare spans almost 20 years, working in every part of the country in senior positions of leadership in the healthcare industry. He led business development for the nation’s largest provider of mobile imaging services, directing its effort to expand into new business areas. McElearney provides overall new business leadership for IBA Inc. in partnering with health facilitates in developing a Proton Therapy Center.

 

Mary Elizabeth (Beth) Klein,
President, IBA Proton Therapy North America

Klein joined IBA in 2009, after more than 25 years with GE Healthcare. There she held various leadership roles including leading the nuclear medicine business and was the Americas commercial executive at TomoTherapy 2005-2007.

 

About IBA

IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer.s. The company is the worldwide technology leader in the field of proton therapy, which is considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single-room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry.

Headquartered in Belgium and employing about 1300 people worldwide, IBA has installed systems across the world. IBA is listed on the Pan-European stock exchange NYSE EURONEXT. (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB) More information can be found at: www.iba-worldwide.com

 

Register for this webinar

Related Content

proton therapy, recurrent lung cancer, clinical study, IMPT, 2017 Multidisciplinary Thoracic Cancers Symposium
News | Proton Therapy | March 24, 2017
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for...
lung cancer, radiation therapy, immune checkpoint inhibitors, 2017 Multidisciplinary Thoracic Cancers Symposium, clinical study
News | Lung Cancer | March 22, 2017
An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors (ICPIs)...
SBRT, stereotactic body radiation therapy, early-stage lung cancer, patients 80 and older, 2017 Multidisciplinary Thoracic Cancers Symposium, study
News | Stereotactic Body Radiation Therapy (SBRT) | March 20, 2017
Patients in their 80s and 90s who have early-stage lung cancer but cannot undergo an operation can be treated safely...
iCAD, Xoft Axxent Electronic Brachytherapy System, eBx, 3,000 early-stage breast cancer patients, Miami Breast Cancer Conference
News | Brachytherapy Systems | March 15, 2017
CAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative...
reducing radiation therapy, breast cancer, cut treatment costs, Duke Cancer Institute study
News | Radiation Therapy | March 14, 2017
March 14, 2017 — Over half of older women with early stage breast cancer received more...
FDG PET/CT, lung cancer, radiation therapy, AJR study, American Journal of Roentgenology
News | Lung Cancer | March 13, 2017
FDG positron emission tomography/computed tomography (PET/CT) is a valuable imaging tool for treatment assessment of...
prostate cancer, radiation therapy, high-dose-rate brachytherapy, HDR, Red Journal study

This is a single-fraction high-dose-rate prostate implant imaging and dosimetry. Image courtesy of Daniel Krauss/American Society for Radiation Oncology (ASTRO)

News | Brachytherapy Systems | March 06, 2017
March 6, 2017 — Results from a new prospective clinical trial indicate high-dose-rate (HDR)...
brain metastases, cancer, survey, UCLA, Dr. Percy Lee, whole brain radiotherapy, stereotactic radiosurgery

Image of a human brain with seven metastases, depicted here as the small colored spheres inside rectangles. Image courtesy of UCLA Jonsson Comprehensive Cancer Center.

News | Radiation Therapy | March 03, 2017
An extensive study by University of California Los Angeles (UCLA) researchers found significant variation in treatment...
brain FUS

Brain FUS uses an array of about 1,000 elements designed to overcome attenuation issues presented by the skull and to diffuse the heating over a large area of the brain to prevent damaging healthly tissue. 

Feature | Radiation Oncology | March 02, 2017 | By Dave Fornell
Focused ultrasound (FUS), also called high-intensity focused ultrasound (HIFU), has gained a lot of interest in recent...
Accuray, cancer patient websites, CyberKnife, TomoTherapy, radiation therapy, radiotherapy, RT
News | Radiation Therapy | March 02, 2017
The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis...
Overlay Init